Displaying items by tag: division of hematology and oncology
On March 25, 2020, the School of Medicine and the Hugh Kaul Precision Medicine Institute issued a request for applications that would change the course of research at UAB. A year later, the 14 selected projects have led to new discoveries, subsequent funding, high impact publications, and much more.
Tagged under
- department of radiology
- department of anesthesiology and perioperative medicine
- precision medicine
- division of pulmonary, allergy and critical care medicine
- division of infectious diseases
- division of hematology and oncology
- division of rheumatology
- department of microbiology
- department of medicine
- department of biochemistry and molecular genetics
UAB Medicine recently established a colorectal oncology clinic to provide a hassle-free experience for diagnosis and treatment.
Tagged under
Clinical trials from the final Department of Medicine divisions recently went live in OnCore, marking the successful completion of another major phase of the implementation plan. OnCore is replacing the older, and no longer supported, SiteMinder system.
Tagged under
- uab school of medicine
- department of medicine
- uab medicine
- division of gastroenterology and hepatology
- division of general internal medicine
- division of gerontology, geriatrics, and palliative care
- division of hematology and oncology
- division of nephrology
- division of preventive medicine
- division of rheumatology
The UAB Comprehensive Cancer Center has received a prominent national Innovator Award from the Association of Community Cancer Centers (ACCC) for its Patient Care Connect Program. The award is given only to ACCC members that are forward-thinking in creating replicable solutions to improve access, quality and value of patient care.
A UAB researcher has received a 2017 Susan G. Komen grant to investigate combination drug therapies for HER2-positive breast cancer.
Tagged under
Recent findings from an innovative nationwide trial indicate that the drug pembrolizumab, when used in combination with standard therapy, may provide positive results for patients with locally advanced breast cancer.
Tagged under
Michael Birrer, a leading medical oncologist at Harvard University, will take the reins as the new director of the UAB Comprehensive Cancer Center, succeeding the retiring Edward Partridge.
Tagged under
The first target for the UAB spinoff Incysus Ltd. will be glioblastoma. Incysus has just received a European patent for its innovative approach to fighting cancer.
Tagged under
A UAB study shows specialized treatment sites contribute to better survival rates for those with acute leukemia.
Tagged under
Research from UAB suggests that nearly half of children with the most common type of leukemia or their parents say they took more medications than they actually did.